FR2494267B1 - Nouveau derive de benzanilide doue d'activite anti-arythmique, son procede de preparation et composition pharmaceutique le contenant - Google Patents

Nouveau derive de benzanilide doue d'activite anti-arythmique, son procede de preparation et composition pharmaceutique le contenant

Info

Publication number
FR2494267B1
FR2494267B1 FR8117391A FR8117391A FR2494267B1 FR 2494267 B1 FR2494267 B1 FR 2494267B1 FR 8117391 A FR8117391 A FR 8117391A FR 8117391 A FR8117391 A FR 8117391A FR 2494267 B1 FR2494267 B1 FR 2494267B1
Authority
FR
France
Prior art keywords
preparation
pharmaceutical composition
composition containing
same
antiarrhythmic activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8117391A
Other languages
English (en)
Other versions
FR2494267A1 (fr
Inventor
Robert F Mayol
Richard E Gammans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FR2494267A1 publication Critical patent/FR2494267A1/fr
Application granted granted Critical
Publication of FR2494267B1 publication Critical patent/FR2494267B1/fr
Expired legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR8117391A 1980-09-18 1981-09-15 Nouveau derive de benzanilide doue d'activite anti-arythmique, son procede de preparation et composition pharmaceutique le contenant Expired FR2494267B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/188,184 US4332803A (en) 1980-09-18 1980-09-18 Benzanilide derivative

Publications (2)

Publication Number Publication Date
FR2494267A1 FR2494267A1 (fr) 1982-05-21
FR2494267B1 true FR2494267B1 (fr) 1986-06-27

Family

ID=22692080

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8117391A Expired FR2494267B1 (fr) 1980-09-18 1981-09-15 Nouveau derive de benzanilide doue d'activite anti-arythmique, son procede de preparation et composition pharmaceutique le contenant

Country Status (25)

Country Link
US (1) US4332803A (fr)
JP (1) JPS5782368A (fr)
AR (1) AR227065A1 (fr)
AT (1) AT378181B (fr)
AU (1) AU526825B2 (fr)
BE (1) BE890418A (fr)
CA (1) CA1183537A (fr)
CH (2) CH650497A5 (fr)
CY (2) CY1370A (fr)
DE (2) DE3153300C2 (fr)
DK (1) DK152121C (fr)
FI (1) FI66597C (fr)
FR (1) FR2494267B1 (fr)
GB (2) GB2084570B (fr)
GR (1) GR75788B (fr)
HK (2) HK5388A (fr)
IE (1) IE51584B1 (fr)
IT (1) IT1209900B (fr)
KE (2) KE3717A (fr)
LU (1) LU83644A1 (fr)
NL (1) NL8104261A (fr)
SE (1) SE445215B (fr)
SG (1) SG30187G (fr)
YU (1) YU42425B (fr)
ZA (1) ZA816348B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618680A (en) * 1980-09-18 1986-10-21 Mead Johnson & Company Benzanilide derivative

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
CA961038A (en) * 1971-03-03 1975-01-14 Joseph L. Minielli Substituted piperidines

Also Published As

Publication number Publication date
DK412881A (da) 1982-03-19
AT378181B (de) 1985-06-25
BE890418A (fr) 1982-03-18
SE8105538L (sv) 1982-03-19
LU83644A1 (fr) 1982-04-14
YU219281A (en) 1984-02-29
GB2084570B (en) 1984-09-05
ZA816348B (en) 1982-09-29
FI812873L (fi) 1982-03-19
YU42425B (en) 1988-08-31
GR75788B (fr) 1984-08-02
IT8149311A0 (it) 1981-09-17
AU7518181A (en) 1982-03-25
CY1370A (en) 1987-08-07
GB2144050B (en) 1985-09-11
CH650497A5 (de) 1985-07-31
CA1183537A (fr) 1985-03-05
FI66597B (fi) 1984-07-31
DK152121B (da) 1988-02-01
JPS5782368A (en) 1982-05-22
CY1377A (en) 1987-08-07
AU526825B2 (en) 1983-02-03
DK152121C (da) 1988-06-20
AR227065A1 (es) 1982-09-15
GB8402839D0 (en) 1984-03-07
SE445215B (sv) 1986-06-09
US4332803A (en) 1982-06-01
FI66597C (fi) 1984-11-12
KE3716A (en) 1987-04-16
KE3717A (en) 1987-04-16
HK5388A (en) 1988-01-29
DE3153300C2 (de) 1987-03-19
HK4488A (en) 1988-01-29
ATA403781A (de) 1984-11-15
IT1209900B (it) 1989-08-30
DE3137084C2 (de) 1986-04-10
GB2144050A (en) 1985-02-27
FR2494267A1 (fr) 1982-05-21
NL8104261A (nl) 1982-04-16
GB2084570A (en) 1982-04-15
IE51584B1 (en) 1987-01-21
DE3137084A1 (de) 1982-05-13
CH651932A5 (de) 1985-10-15
SG30187G (en) 1987-07-17
IE812160L (en) 1982-03-18
JPH0256351B2 (fr) 1990-11-29

Similar Documents

Publication Publication Date Title
FR2511357B1 (fr) Cis-platine microcristallin, son procede de preparation et composition pharmaceutique le contenant
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
FR2518095B1 (fr) Nouveaux l-oxa-, thia- et aza-spirocyclo-benzene-acetamides et benzamides, leur procede de preparation et composition pharmaceutique les contenant
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
BE885812A (fr) Derives d'acides 6beta-hydroxyalkylpenicillaniques, leur procede de production et compositions pharmaceutiques les contenant
FR2495154B1 (fr) 5'-aminoalkyl-4', 4, 8-trialkylpsoralenes, leur procede de production et composition pharmaceutique les contenant
BE868173A (fr) Nouveaux hexahydro-1-hydroxy-9-hydroxymethyl-6h-dibenzo-(b,d)pyranes substitues en position 3, leur procede de preparation et composition pharmaceutique les contenant
BE861964A (fr) Derives de la 1,4-dihydropyridine, leur procede d'obtention et composition pharmaceutique les contenant
BE872347A (fr) Amides substitues de l- et dl-phenylglycine, leur procede de production et composition pharmaceutique les contenant
FR2569702B1 (fr) Nouvelle 4'-deschlororebeccamycine, composition pharmaceutique la contenant et procede pour sa preparation
FR2473308B1 (fr) Composition pharmaceutique a effet prolonge et son procede de preparation
BE885156A (fr) Psoralenes, leur procede de preparation et compositions pharmaceutiques les contenant
FR2518091B1 (fr) 23-dehydro-25-hydroxyvitamine d3, son procede de preparation et composition pharmaceutique la renfermant
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
FR2450814B1 (fr) 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit
BE884620A (fr) Nouveaux derives d'halovincamone, leur procede de preparation et medicaments les contenant
BE883631A (fr) Nouveau compose a activite antiepileptique et anticonvulsivante son procede de preparation et compositions pharmaceutiques le contenant
PT76348A (fr) Isomere levogyre de la mequitazine son procede de preparation et medicaments le contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2494267B1 (fr) Nouveau derive de benzanilide doue d'activite anti-arythmique, son procede de preparation et composition pharmaceutique le contenant
FR2558828B1 (fr) " 1a,25-dihydroxy-22z-deshydrovitamine d " composition pharmaceutique et procede de preparation
FR2510571B1 (fr) Spirothiazolidinedione, son procede de production et preparation pharmaceutique la contenant
BE882535A (fr) Nouveaux derives de la phenothiazine et leur procede de preparation, et medicaments contenant lesdits derives
FR2468598B1 (fr) Thiazolidones-4 substituees en 2, leur procede de preparation et les medicaments les contenant
LU79600A1 (fr) Nouveaux derives de phenylglycine,leur procede de preparation et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
ST Notification of lapse